30. HIỆU QUẢ ĐIỀU TRỊ CỦA VIÊN NANG “HẠ MỠ NK” TRÊN MỘT SỐ CHỈ SỐ XƠ VỮA ĐỘNG MẠCH
Nội dung chính của bài viết
Tóm tắt
Objectives: Evaluate the effect of improving AI, CRI, AIP and CAVI indexes of “Ha mo NK” capsules on atherosclerosis patients. Compare before and after treatment
Subject and methods: A randomized, controlled clinical trial with pre- and post-treatment comparisons conducted on 60 patients diagnosed with atherosclerosis. The patients were divided into two groups: the study group received “Ha mo NK” capsules (525 mg), 6 capsules/day, taken in two divided doses at 8:00 AM and 15:00 PM. The control group received Atorvastatin 10 mg, 1 capsules/day, taken at 8:00 PM. The treatment duration was 60 days.
Results: “Ha mo NK” capsules were effective in reducing AI index by 26.04%; CRI index by 21.33%; AIP index by 37.93%; CAVI index by 3.13% with statistical significance with p < 0.001 equivalent to the Atorvastatin group: reducing AI index by 26.03%; CRI index by 20.95%; AIP index by 46.15%; 3.91% CAVI index with p < 0.001.
Conclusions: “Ha mo NK” capsule has anti-atherosclerosis effects through AI, CRI, CRI and CAVI indexes equivalent to the Atorvasatin group.
Chi tiết bài viết
Từ khóa
Xơ vữa động mạch, viên nang “Hạ mỡ NK
Tài liệu tham khảo
[2] White J, Swedlow D.I, Preiss D et al, Association of lipid fractions at risk for coronary artery disease and diabetes, JAMA Cardiol, 2016, 1 (6), pp. 692-699.
[3] Pham Thuy Phuong, Effect of “Ha Mo NK” hard capsule on experimental atherosclerosis model, Journal of medical research, 2021, 141(5), E8, 95-10.
[4] Pham Quoc Binh, Pham Thuy Phuong, Toxicity evaluation of acute and sub-chronic oral toxicity of hamo NK hard capsule in experimental animals, Journal of medical research, 2020, 136 E7 (12), 40-47.
[5] Pham Thuy Phuong, Effects of “Ha mo NK” hard capsule on serum lipid profiles in dyslipidemia experimental animals, Journal of Medical Research, 2021, 141 (5), 10-18
[6] Hội Tim mạch học Việt Nam, Khuyến cáo về dự phòng bệnh lý tim mạch trong thực hành lâm sàng, 2022, tr. 31-33.
[7] Nguyễn Nghiêm Luật, Ý nghĩa lâm sàng của các lipid lipoprotein và các tỷ số của chúng, Bệnh viện Đa khoa Medlatec, 2019.
[8] Mikhin V.P et al, Hypolipidemic and pleiotropic efficacy of rosuvastatin in arterial hypertension patients of high cardiovascular risk in long-term outpatient follow-up, Russian Journal of Cardiology, 2016, 140 (12), 90-96.